학술논문
Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis (Rheumatology and Therapy, (2023), 10, 5, (1255-1276), 10.1007/s40744-023-00576-8)
Document Type
Erratum
Author
Source
In: Rheumatology and Therapy . (Rheumatology and Therapy, February 2024, 11(1):221-222)
Subject
Language
English
ISSN
21986584
21986576
21986576